FZMD — Fuse Medical Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $4.51m
- $6.48m
- $18.64m
Annual income statement for Fuse Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.3 | 22.9 | 21.4 | 20.4 | 18.6 |
Cost of Revenue | |||||
Gross Profit | 13 | 11.1 | 12.7 | 11.9 | 11.5 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 28.3 | 27.3 | 22.4 | 22.2 | 19.5 |
Operating Profit | -1.96 | -4.35 | -1.03 | -1.83 | -0.815 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3.57 | -2.54 | -1.41 | -1.57 | 3.12 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3.96 | -3.32 | -1.43 | -1.59 | 3.1 |
Net Income Before Extraordinary Items | |||||
Net Income | 3.96 | -3.32 | -1.43 | -1.59 | 3.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.96 | -3.32 | -1.43 | -1.59 | 3.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.057 | -0.039 | -0.02 | -0.026 | 0.04 |